Korean Drug Co Ltd - ESG Rating & Company Profile powered by AI
Detailed ESG analysis of Korean Drug Co Ltd are reached by logging in. The analysis of Korean Drug Co Ltd was prepared by All Street Sevva using leading NLP. If you are employed by Korean Drug Co Ltd and you wish to licence your ESG rating, please get in touch.
Korean Drug Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Korean Drug Co Ltd | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Korean Drug Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Korean Drug Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes Korean Drug Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Korean Drug Co Ltd use carbon offsets or credits exclusively for residual emissions (typically less than ~0.5–5% of total emissions)?
Sign up for free to unlockDoes Korean Drug Co Ltd offer flexible work?
Sign up for free to unlockDoes Korean Drug Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Korean Drug Co Ltd plan to change its portfolio composition to lower the emissions intensity of its energy mix (e.g., by shifting from oil to gas, or by adding lower-carbon options like hydrogen, e-fuels, bioenergy, etc.)?
Sign up for free to unlockDoes Korean Drug Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Korean Drug Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose water use targets?
Sign up for free to unlockDoes Korean Drug Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Korean Drug Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Korean Drug Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Korean Drug Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockDoes Korean Drug Co Ltd explicitly state that carbon offsets or credits are separate from its emissions-reduction progress or that they are not counted toward its emissions-reduction targets?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Korean Drug Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Korean Drug Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Korean Drug Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose its waste policy?
Sign up for free to unlockDoes Korean Drug Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Korean Drug Co Ltd plan to mitigate emissions from future new production assets through measures such as electrifying equipment, carbon capture and storage, repurposing waste gas, methane leak detection and repair, eliminating flaring, etc.?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose energy use targets?
Sign up for free to unlockDoes Korean Drug Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Korean Drug Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Korean Drug Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Korean Drug Co., Ltd. develops, manufactures, and sales medicines for treating various diseases in South Korea. The company provides medicines for treating central nervous system and cold. It also offers prescription drugs, including antibiotic, antifungal, digestive system medicine, circulatory system, psychiatric, and central nervous system drugs; drugs for the urinary system, and skinantiviral. In addition, the company provides over the counter drugs comprising drugs for liver disease and cold medicine, as well as offers health functional foods. Further, the company offers xprugel, a transparent gel for disinfection of hands and skin. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea.